Literature DB >> 9043447

Mass or high-risk screening for abdominal aortic aneurysm.

J S Lindholt1, E W Henneberg, H Fasting, S Juul.   

Abstract

BACKGROUND: Abdominal aortic aneurysm (AAA) is known to be associated with various diseases, especially hypertension, acute myocardial infarction (AMI), chronic obstructive airway disease (COAD), and intermittent claudication. These associations have led to a debate about whether screening of older men for AAA should be restricted to those with an associated disease.
METHODS: To compare mass screening of men for AAA with screening of men with AAA-associated diseases, all previous computerized hospital-recorded AAA-associated diseases were merged with the results of mass screening of 4404 men aged 65-73 years.
RESULTS: Of hypertensives, 82.6 per cent attended screening of whom 17.8 per cent had AAA. For previous AMI the equivalent values were 82.3 and 9.3 per cent; for COAD 74.3 and 7.7 per cent; for angina pectoris 83.8 and 7.5 per cent; for lower limb arteriosclerosis 81.1 and 6.1 per cent; and for stroke or transient cerebral ischaemia 75.0 and 6.2 per cent. Screening of these six high-risk groups alone would have required 78.5 per cent fewer scans and 51.1 per cent of the AAAs diagnosed at mass screening would have been recognized. The attendance rate would have been 80.4 per cent, of whom 9.5 per cent would have had an aneurysm. The attendance rate among non-high-risk men was 74.7 per cent and 2.7 per cent had an aneurysm.
CONCLUSION: If screening for AAA is desirable, the authors recommend mass rather than high-risk screening.

Entities:  

Mesh:

Year:  1997        PMID: 9043447

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Screening for abdominal aortic aneurysms during a basic medical checkup in residents of a Japanese rural community.

Authors:  K Adachi; T Iwasawa; T Ono
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Screening of abdominal aortic aneurysm: a pragmatic approach.

Authors:  C Kyriakides; J Byrne; S Green; N R Hulton
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

3.  Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA.

Authors:  Marc D Silverstein; Stephen R Pitts; Elliot L Chaikof; David J Ballard
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

4.  French women from multiplex abdominal aortic aneurysm families should be screened.

Authors:  Claire Le Hello; Fabien Koskas; Philippe Cluzel; Zoubida Tazi; Corina Gallos; Jean Charles Piette; Elisabeth Tournier Lasserve; Edouard Kieffer; Patrice Cacoub
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

5.  Screening for abdominal aortic aneurysms: single centre randomised controlled trial.

Authors:  Jes S Lindholt; Svend Juul; Helge Fasting; Eskild W Henneberg
Journal:  BMJ       Date:  2005-03-09

6.  Use of a Web-based clinical decision support system to improve abdominal aortic aneurysm screening in a primary care practice.

Authors:  Rajeev Chaudhry; Sidna M Tulledge-Scheitel; Doug A Parks; Kurt B Angstman; Lindsay K Decker; Robert J Stroebel
Journal:  J Eval Clin Pract       Date:  2011-03-15       Impact factor: 2.431

7.  Feasibility and accuracy of a novel automated three-dimensional ultrasonographic analysis system for abdominal aortic aneurysm: comparison with two-dimensional ultrasonography and computed tomography.

Authors:  In-Jeong Cho; Jinyong Lee; Jinki Park; Sang-Eun Lee; Chul-Min Ahn; Young-Guk Ko; Donghoon Choi; Hyuk-Jae Chang
Journal:  Cardiovasc Ultrasound       Date:  2020-07-01       Impact factor: 2.062

8.  Aortic aneurysm screening in a high-risk population: a non-contrast computed tomography study in korean males with hypertension.

Authors:  In-Jeong Cho; Sung-Yeol Jang; Hyuk-Jae Chang; Sanghoon Shin; Chi Young Shim; Geu-Ru Hong; Namsik Chung
Journal:  Korean Circ J       Date:  2014-05-20       Impact factor: 3.243

9.  The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.

Authors:  Axel Cosmus Pyndt Diederichsen; Lars Melholt Rasmussen; Rikke Søgaard; Jess Lambrechtsen; Flemming Hald Steffensen; Lars Frost; Kenneth Egstrup; Grazina Urbonaviciene; Martin Busk; Michael Hecht Olsen; Hans Mickley; Jesper Hallas; Jes Sanddal Lindholt
Journal:  Trials       Date:  2015-12-05       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.